Regensight is a startup company exploiting proprietary theranostics technology for incision free treatment of visual disorders. Theranostics is our disruptive medical solution, which is based on therapy guided by advanced imaging diagnostics for providing non-invasive correction of visual disorders. Our first medical product is C4V CHROMO4VIS, a breaktrough medical device incorporating exponential and key-enabling technologies for corneal cross-linking. We are elevating the standard of care for keratoconus treatment with unparalleled cutting edge technologies.